NPPA caps retail prices of 30 drug formulations spanning diabetes, BP, heart and antibiotics
India's drug pricing regulator NPPA has fixed ceiling prices on 30 formulations, with new caps including Rs 14.88/tablet, Rs 11.91/tablet and Rs 127/capsule across diabetes, hypertension, cardiac and women's health categories. Chemist body AIOCD expects revised MRP stock on pharmacy shelves within 60-90 days as existing inventory clears.
What happened
NPPA capped retail prices of 30 drug formulations covering diabetes, BP, heart, antibiotics and women's health. Chemists expect revised MRP stock to hit
Key facts
- 30 formulations
- Rs 14.88/tablet
- Rs 11.91/tablet
- Rs 10.17/tablet
- Rs 18.46/tablet
- Rs 127/capsule
- 60-90 days
Why this matters
Pricing-led margin reset on 30 formulations sharpens the case for portfolio rebalancing toward non-NLEM and chronic-care brands, and may soften valuations of pharma retail and generic targets in the near term.